Your browser is no longer supported. Please, upgrade your browser.
Pulse Biosciences, Inc.
Index- P/E- EPS (ttm)-2.15 Insider Own46.70% Shs Outstand25.22M Perf Week-8.82%
Market Cap758.63M Forward P/E97.90 EPS next Y0.30 Insider Trans0.00% Shs Float13.48M Perf Month-14.00%
Income-49.90M PEG- EPS next Q-0.52 Inst Own12.00% Short Float8.34% Perf Quarter99.80%
Sales- P/S- EPS this Y-3.00% Inst Trans5.48% Short Ratio7.19 Perf Half Y199.39%
Book/sh1.30 P/B22.59 EPS next Y115.20% ROA-107.20% Target Price46.00 Perf Year322.59%
Cash/sh1.15 P/C25.63 EPS next 5Y- ROE-152.90% 52W Range5.11 - 45.82 Perf YTD23.09%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-35.90% Beta1.68
Dividend %- Quick Ratio5.10 Sales past 5Y- Gross Margin- 52W Low474.76% ATR3.17
Employees82 Current Ratio5.10 Sales Q/Q- Oper. Margin- RSI (14)41.30 Volatility8.22% 10.22%
OptionableYes Debt/Eq0.00 EPS Q/Q9.60% Profit Margin- Rel Volume1.13 Prev Close29.45
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume156.36K Price29.37
Recom2.00 SMA20-18.13% SMA50-2.08% SMA20078.92% Volume176,163 Change-0.27%
Jan-26-21Reiterated H.C. Wainwright Buy $16 → $40
May-12-20Upgrade H.C. Wainwright Neutral → Buy $6 → $16
Feb-14-20Downgrade H.C. Wainwright Buy → Neutral $26 → $6
Feb-25-19Initiated H.C. Wainwright Buy $27
Feb-22-21 04:05PM  
Feb-20-21 09:36AM  
Feb-19-21 08:00AM  
Feb-16-21 08:00AM  
Feb-12-21 08:00AM  
Feb-04-21 08:30AM  
Feb-03-21 09:00AM  
Jan-25-21 08:00AM  
Jan-12-21 07:00AM  
Jan-11-21 06:11AM  
Jan-05-21 09:00AM  
Dec-15-20 04:38PM  
Dec-04-20 08:00AM  
Nov-11-20 04:05PM  
Nov-09-20 08:30PM  
Oct-28-20 04:05PM  
Oct-07-20 07:30AM  
Oct-01-20 07:30AM  
Sep-29-20 07:30AM  
Sep-15-20 04:14PM  
Sep-01-20 04:05PM  
Aug-11-20 01:30AM  
Aug-10-20 04:05PM  
Aug-06-20 04:05PM  
Jul-27-20 04:05PM  
Jul-01-20 04:05PM  
Jun-16-20 08:12PM  
Jun-10-20 09:10AM  
Jun-08-20 06:46PM  
May-14-20 05:38PM  
May-11-20 04:05PM  
May-01-20 09:10AM  
Apr-29-20 04:05PM  
Apr-24-20 07:24AM  
Apr-21-20 09:46AM  
Apr-06-20 09:10AM  
Mar-17-20 04:05PM  
Mar-16-20 04:05PM  
Mar-09-20 04:46PM  
Feb-14-20 08:23AM  
Feb-13-20 05:44PM  
Jan-29-20 09:41PM  
Jan-20-20 11:07AM  
Dec-30-19 06:35AM  
Dec-18-19 09:00AM  
Dec-16-19 05:26PM  
Nov-18-19 08:32PM  
Nov-07-19 03:44PM  
Oct-31-19 01:51PM  
Oct-22-19 11:53AM  
Oct-17-19 07:52PM  
Oct-15-19 07:40PM  
Oct-01-19 04:34PM  
Sep-17-19 09:02PM  
Sep-04-19 07:01PM  
Aug-21-19 10:16AM  
Aug-16-19 04:56PM  
Aug-09-19 04:24AM  
Aug-08-19 04:02PM  
Aug-06-19 08:00AM  
Jul-25-19 04:20PM  
Jun-17-19 07:22PM  
May-23-19 01:44PM  
May-15-19 04:27PM  
Apr-30-19 10:24PM  
Apr-17-19 07:27PM  
Apr-15-19 05:00PM  
Mar-26-19 02:57PM  
Mar-19-19 08:00AM  
Mar-15-19 04:33PM  
Mar-01-19 08:00AM  
Feb-28-19 04:00PM  
Feb-15-19 04:31PM  
Feb-07-19 09:56PM  
Jan-28-19 08:56PM  
Jan-17-19 04:39PM  
Jan-15-19 05:25PM  
Jan-07-19 08:00AM  
Dec-25-18 10:53AM  
Dec-17-18 05:31PM  
Dec-14-18 04:35PM  
Dec-11-18 07:50AM  
Dec-07-18 09:11AM  
Nov-19-18 05:14PM  
Nov-15-18 04:48PM  
Nov-07-18 11:51PM  
Nov-02-18 07:20AM  
Oct-30-18 04:03PM  
Oct-25-18 08:46AM  
Oct-23-18 04:05PM  
Oct-15-18 04:24PM  
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It engages in the research and development, and commercialization of CellFX system that provides a precise and non-thermal cellular treatment technology delivering nanosecond duration energy pulses that impact cells in treated tissue while sparing surrounding non-cellular tissue primarily for dermatology applications. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was founded in 2014 and is headquartered in Hayward, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Zanganeh MakyDirectorJun 23Buy10.701,19312,767106,767Jun 25 05:12 PM
Zanganeh MakyDirectorJun 17Buy7.017,95055,730105,574Jun 19 04:22 PM